International Clinical Trial: A prospective, single-arm, exploratory clinical study of ivonescimab injection (AK112) combined with chemotherapy in the treatment of stage III unresectable non-small cell lung cancer

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122824) titled 'A prospective, single-arm, exploratory clinical study of ivonescimab injection (AK112) combined with chemotherapy in the treatment of stage III unresectable non-small cell lung cancer' on April 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shanghai Chest Hospital

Condition: Patients with stage III non-resectable NSCLC (discussed by the MDT panel) without EGFR/ALK/ROS1/RET mutations

Intervention: Single Arm:Ivosimanab (AK112) 20mg/kg Q3W combined with platinum-based doublet chemotherapy (squamous cell carcinoma: cisplatin/carboplatin + paclitaxel/nab-paclitaxel non-squ...